Redeye updates its fair value range following the announced rights issue. As we do not yet know the full terms, the new fair value range is up for change again after the subscription price is set. There was also a slight delay on revenues, impacting when Smart Eye is estimated to reach a cash flow positive state. However, Smart Eye did also announce a great deal of new design wins, impacting our view of its market share.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.